Bachem webinar on fluorescent labelling of peptides

Bubendorf, Switzerland: – Peptide technology specialist Bachem AG is to host an international webinar on Fluorescently-Labeled Peptides in late October.

The one-hour webinar ‘Fluorescently-Labeled Peptides – Choosing the Best Dye and Designing the Best Peptide’ will be hosted free on xTalks (www.xtalks.com) on October 23, 2018, opening 1400 hrs. UTC (1000 hrs. EDT, 1500 BST, 1700 CEST). Registration is now open at xTalks (see Resources).

Third global pillar

Senior Bachem specialists will share insights on fluorescent dyes, imaging, peptides and custom synthesis, aimed at a practicing audience of research scientists and associates, Postdocs and PhDs, scientific advisors and R&D directors as well as product and marketing managers and diagnostics professionals from in vivo imaging, flow cytometry and microscopy labs.

This is the first webinar that Bachem has hosted since its successful session on “Peptides in Alzheimer’s Disease Research” staged in 2016.

Bachem’s decision to stage the English language webinar reflects increasing pharma industry and academic use of synthetic molecular probes labeled with fluorescent dyes as an invaluable technology for biochemical and cellular studies using confocal fluorescence microscopy.

Selecting the right substrate

Bachem speakers will be Dr. Susanne Rodler and Dr. Stefanie Dobitz, both Sales Managers for Custom Synthesis and Marketing Specialist Dr. Erik Schrader.

They will present an overview of known dye labels and highlight new developments in this field, such as dyes suitable for the study of complex processes, such as receptor-ligand interactions or the visualization of cellular structures. We will also illustrate how to compare the performance of individual dye labels and give an overview over the commercially available options.

“We will showcase our synthetic capabilities as well as our portfolio of fluorescently labelled peptides and custom synthesis offerings,” explained Dr. Rodler. “In particular, we will be showing how to design the right substrate for your imaging applications,” she explained.

“It’s all part of our role as a Pioneering Partner for Peptides in helping our customers and partners get the very best out of the available technology,” said Dr. Rodler.

The webinar will include polling questions and a Q&A session, with opportunities afterwards for registered participants to contact speakers directly.

About Bachem

The Bachem Group is a listed, technology-based company focused on peptide chemistry. Bachem is the world’s only full service provider of peptides and provides a full range of other services to the pharma and biotech industries.

Under its banner Pioneering Partner for Peptides, Bachem specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients (APIs). A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete its service portfolio.

Headquartered in Switzerland with subsidiaries in Europe, the US and Asia, the group has a global reach with more experience and know-how than any other company in the industry. Bachem shows total commitment to quality, innovation and partnership, prioritizing continuous investment in R&D on chemistries and technologies as crucial for future success. Its ever-increasing knowledge of complex proteins and peptides derives from ongoing research in proteomics, as well as progress in mass spectrometry, synthesis and ligation technologies, complemented by collaboration with external research institutions.

Bachem has six production sites in the U.S. and in Europe along with research level production and full cGMP manufacturing facilities on both continents. These provide capacity to produce APIs, key intermediates, small molecule generics, new chemical entities (NCEs) and finished dosage forms at preclinical, clinical and production scales.

Resources

Click on Webinar registration to enrol for the event.
Click on Bachems News to see latest News & Events.